Drug Dilemmas: Medicines, Interactions and Adverse Effects (NW190207B)
Availability | Course has taken place |
Subject | Bisphosphonates |
Description | Medicines in dentistry can be challenging for the dental team. Come along to this half day session which has been designed for clinicians treating patients with complex medical histories, to aid understanding of implications in dentistry, drug interactions and what can be done to minimise the risk. |
Additional information | The session will include commonly used medicines in dentistry and how to overcome the challenges faced by practitioners. Christine Randall is a pharmacist and lead for the National Dental Medicines Information Service. Registration is from 9am-9.30am |
Venue | Regatta Place, Liverpool - Merseyside View details |
Date & time | Thursday 7 February 2019, 09:30 to 12:30 |
Lecturer | Christine Randall View details |
Target audience | Mandatory: Dental Hygienist, or Dental Therapist, or Dentist |
Development outcome | C |
Course style | Lecture |
Core topic | Not a core topic |
Catering | Refreshments |
CPD hours | 2:45 |
Cost | £20.00 |
Aims | Focusing on issues relevant to the dental team, to raise awareness of:
|
Objectives | To manage medicines within the current legal framework: Medicines are highly regulated in the UK and knowing which aspects of the law are relevant to dental practice is essential. The session will cover:
To minimise risk to patients by raising awareness of drug interactions when prescribing and administering medicines: All medicines have the potential to cause or be affected by drug interactions. Some of the drug interactions that are clinically relevant and impact most in dental practice will be discussed. Polypharmacy, the concurrent use of multiple medications, is an increasingly common especially in older patients introducing challenges to dentists when additional medicines are required. To identify some important oral adverse drug reactions and report them appropriately to the Yellow Card Scheme. :All medicines cause adverse effects – not in all patients and not always severe. Adverse drug reactions (ADRs) that may be seen by the dental team are highlighted including osteonecrosis of the jaw associated with bisphosphonates. Reporting ADRs is an important professional responsibility for all members of the dental healthcare team and how this should be done via the MHRAs Yellow Card Scheme will be described. To recognise areas of concern when treating patients on medicines or using medicines to treat patients. Patients taking medicines can provide challenges for the dental team but sometimes appropriate use of commonly used medicines is also unclear, the following will be covered:
|
Learning outcomes | Delegates will be able to:
|